| Detected | Trial | Change |
|---|---|---|
| 2026-08-15 | NCT05020236 A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in… |
Trial sites expanded: 90 -> 237 locations |
| 2026-08-15 | NCT05020236 A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in… |
date change Primary completion moved earlier: 2026-04-27 -> 2026-02-26 |
| 2026-08-15 | NCT07028853 This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat… |
Trial sites reduced: 341 -> 337 locations |
| 2026-08-15 | NCT07089680 A Study to Learn About the Study Medicine Paxlovid (Nirmatrelvir + Ritonavir) in Adults… |
Completed without a posted recruiting period |
| 2026-08-15 | NCT07089680 A Study to Learn About the Study Medicine Paxlovid (Nirmatrelvir + Ritonavir) in Adults… |
Enrollment reduced: 1200 -> 937 participants |
| 2026-08-15 | NCT07089680 A Study to Learn About the Study Medicine Paxlovid (Nirmatrelvir + Ritonavir) in Adults… |
Trial sites expanded: 0 -> 7 locations |
| 2026-08-15 | NCT07089680 A Study to Learn About the Study Medicine Paxlovid (Nirmatrelvir + Ritonavir) in Adults… |
date change Primary completion pushed: 2025-11-30 -> 2026-05-29 |
| 2026-08-15 | NCT07089680 A Study to Learn About the Study Medicine Paxlovid (Nirmatrelvir + Ritonavir) in Adults… |
date change Completion pushed: 2025-11-30 -> 2026-05-29 |
| 2026-08-15 | NCT07282665 A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and… |
Trial sites expanded: 174 -> 183 locations |
| 2026-08-14 | NCT06873945 A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia… |
Enrollment reopened |
| 2026-08-14 | NCT06873945 A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia… |
Primary endpoint(s) modified |
| 2026-08-14 | NCT06873945 A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia… |
Enrollment increased: 550 -> 1330 participants |
| 2026-08-14 | NCT06873945 A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia… |
Trial arms changed: 4 -> 5 |
| 2026-08-14 | NCT06873945 A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia… |
Trial sites expanded: 143 -> 147 locations |
| 2026-08-14 | NCT06873945 A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia… |
date change Primary completion pushed: 2026-12-21 -> 2028-03-19 |
| 2026-08-14 | NCT06873945 A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia… |
date change Completion pushed: 2026-12-21 -> 2028-03-19 |
| 2026-08-14 | NCT05675449 A Clinical Trial of Four Medicines (Elranatamab Plus Carfilzomib and Dexamethasone or… |
date change Primary completion pushed: 2025-07-07 -> 2026-03-11 |
| 2026-08-13 | NCT05890612 A Study on Paxlovid Once in the Market, to Observe Its Safety and Effectiveness in… |
date change Primary completion moved earlier: 2029-07-13 -> 2029-02-17 |
| 2026-08-13 | NCT05890612 A Study on Paxlovid Once in the Market, to Observe Its Safety and Effectiveness in… |
date change Completion moved earlier: 2029-07-13 -> 2029-02-17 |
| 2026-08-12 | NCT03307980 Long-term Safety and Efficacy Study and Dose-Escalation Substudy of PF 06838435 in… |
Trial completed |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-14 | NCT07765888 A Study to Learn About the Study Medicine Called Tilrekimig in People With… | Phase 3 | Not Yet Recruiting |
| 2026-08-10 | NCT07754539 A Study to Evaluate 20vPnC in Healthy Chinese Infants | Phase 3 | Recruiting |
| 2026-07-29 | NCT07733765 A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment… | Phase 3 | Not Yet Recruiting |
| 2026-07-28 | NCT07731100 A Study to Learn About How Food Affects the Uptake of Study Medicine Prifetrastat Into… | Phase 1 | Not Yet Recruiting |
| 2026-07-28 | NCT07731139 A Study to Learn How Different Amounts of the Study Medicine Called PF-08642534 Are… | Phase 1 | Not Yet Recruiting |
| 2026-07-27 | NCT07729462 A Study to Learn About the Study Medicine Called Rimegepant in Adults When Used for the… | Phase 3 | Not Yet Recruiting |
| 2026-07-24 | NCT07725809 A Study to Learn How the Study Medicine Called PF-08653945 is Taken up Into the Blood in… | Phase 1 | Not Yet Recruiting |
| 2026-07-23 | NCT07721402 A Study to Learn About How Different Forms of Study Medicine Prifetrastat Are Taken Up… | Phase 1 | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT05203172 | The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and… | Solid Tumors | Recruiting |
| NCT06057402 | Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM) | Multiple Myeloma | Recruiting |
| NCT06952660 | Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical… | Cervical Cancer | Recruiting |
| NCT07609914 | A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant… | Acute Treatment of Migraine | Recruiting |
| NCT05144997 | Lorlatinib Continuation Study | Non-Small-Cell Lung Cancer | Active, Not Recruiting |
| NCT05160922 | Crizotinib Continuation Clinical Study | NSCLC | Active, Not Recruiting |
| NCT05295290 | A Study to Learn About The COVID-19 (Study) Vaccine (Called COMIRNATY) in People That Are… | Myocarditis | Active, Not Recruiting |
| NCT07685769 | A Study to Find Out if the Medicine Called Rimegepant is Safe for Adults in India | Acute Treatment of Migraine | Not Yet Recruiting |
| Phase 3 | |||
| NCT05261139 | EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332… | COVID-19 | Recruiting |
| NCT07029828 | A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With… | Severe Alopecia Areata | Recruiting |
| NCT07062965 | A Study to Learn About the Study Medicine Called PF-07248144 in Combination With… | Breast Cancer | Recruiting |
| NCT07500506 | A Study to Learn About the Safety, Tolerability, and Immunogenicity of a Fifth Dose of… | Lyme Disease | Recruiting |
| NCT06698796 | A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic… | Dermatomyositis | Recruiting |
| NCT05568719 | Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in… | Hemophilia A | Recruiting |
| NCT05895786 | A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active… | Myositis | Recruiting |
| NCT07543380 | A Study to Learn Safety and Immune Response to Study Vaccine -RSVpreF in Adults at High… | Respiratory Syncytial Virus (RSV) | Recruiting |
| NCT05145127 | Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without… | Hemophilia A | Recruiting |
| NCT05623020 | A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and… | Multiple Myeloma | Recruiting |
| NCT06641466 | A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for… | Menstrual Migraine | Recruiting |
| NCT07160244 | BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women… | Healthy | Recruiting |
| NCT07629440 | A Study to Learn About How a New Pneumococcal Vaccine Works in Infants. | Pneumococcal Disease | Recruiting |
| NCT07660198 | Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal… | Pneumococcal Disease | Recruiting |
| NCT05253651 | A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in… | Colorectal Neoplasms | Recruiting |
| NCT06758401 | This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug… | Non-Small Cell Lung Cancer | Recruiting |
| NCT06807268 | A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age… | Eczema | Recruiting |